Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stockholders' Deficit (Tables)

v3.10.0.1
Note 5 - Stockholders' Deficit (Tables)
3 Months Ended
Sep. 30, 2018
Stockholders' deficit:  
Schedule of Warrant Activity
    Number    

Weighted Average

Exercise Price Per

Share

   

Remaining Contract

Term (# years)

 
Shares purchasable under outstanding warrants at June 30, 2018     1,740,790     $ 2.03       0.74  
Stock purchase warrants exercised     (40,000 )   $ 2.00       -  
Shares purchasable under outstanding warrants at September 30, 2018     1,700,790     $ 2.03       0.47  
Schedule of Stock Option Activity

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2018     3,544,473     $ 0.83       8.87  
Granted     335,264                  
Exercised     -                  
Forfeited and cancelled     103,125                  
Outstanding at September 30, 2018     3,766,612     $ 0.94       8.33  
Exercisable at September 30, 2018     1,609,667     $ 0.77       7.99  

 

   

Number of

Shares

   

Weighted

Average

Exercise Price

   

Weighted

Average

Remaining

Contract

Term (# years)

 
Outstanding at June 30, 2017     716,277     $ 1.01        
Granted     -                
Exercised     -                
Forfeited and cancelled     -                
Outstanding at September 30, 2017     716,277     $ 1.01       6.83  
Exercisable at September 30, 2017     612,623     $ 1.09       6.60  

 

Schedule of Stock-based Compensation
Three months ended September 30,   2018     2017  
Research and development   $ 15,000     $ 8,000  
General and administrative     149,000       3,000  
Total stock-based compensation expense   $ 164,000     $ 11,000  
Schedule of Stock Options Valuation Assumptions
Three months ended September 30,   2018     2017  
Expected volatility     142 %     100 %
Risk free interest rate     2.63 %     1.31 %
Forfeiture rate     20.0 %     23.0 %
Dividend yield     0 %     0 %
Expected term (years)     5       3